Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
Copyright: Beijing Minhai Biological Technology Co., Ltd. Beijing ICP 10007676 Powered by www.300.cn Beijing Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173
Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Medical support: 010-59613669
Recombinant shingles vaccine approved for listing
Recently, in order to implement the spirit of the executive meeting of the State Council, the State Food and Drug Administration has continued to accelerate the clinical registration of overseas urgently needed drugs imported from China. The State Drug Administration has conditionally approved the reorganization of herpes zoster vaccine (English name: Herpes zoster vaccine (recombinant, adjuvanted)) Import registration application for the prevention of herpes zoster in adults 50 years and over.